Trade-Ideas LLC identified

PRA Health



) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified PRA Health as such a stock due to the following factors:

  • PRAH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.1 million.
  • PRAH has traded 34.3581999999999965211827657185494899749755859375 options contracts today.
  • PRAH is making at least a new 3-day high.
  • PRAH has a PE ratio of 33.
  • PRAH is mentioned 1.29 times per day on StockTwits.
  • PRAH has not yet been mentioned on StockTwits today.
  • PRAH is currently in the upper 20% of its 1-year range.
  • PRAH is in the upper 35% of its 20-day range.
  • PRAH is in the upper 45% of its 5-day range.
  • PRAH is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRAH with the Ticky from Trade-Ideas. See the FREE profile for PRAH NOW at Trade-Ideas

More details on PRAH:

PRA Health Sciences, Inc., a contract research organization, provides various product development services for pharmaceutical and biotechnology companies worldwide. PRAH has a PE ratio of 33. Currently there are 4 analysts that rate PRA Health a buy, no analysts rate it a sell, and 2 rate it a hold.

The average volume for PRA Health has been 336,400 shares per day over the past 30 days. PRA Health has a market cap of $2.6 billion and is part of the health care sector and health services industry. Shares are down 0.2% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates PRA Health as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins.

Highlights from the ratings report include:

  • The revenue growth came in higher than the industry average of 4.0%. Since the same quarter one year prior, revenues rose by 15.9%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • Powered by its strong earnings growth of 215.38% and other important driving factors, this stock has surged by 37.20% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, our hold rating indicates that we do not recommend additional investment in this stock despite its gains in the past year.
  • When compared to other companies in the Life Sciences Tools & Services industry and the overall market, PRA HEALTH SCIENCES INC's return on equity is below that of both the industry average and the S&P 500.
  • The gross profit margin for PRA HEALTH SCIENCES INC is currently lower than what is desirable, coming in at 29.70%. Regardless of PRAH's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.64% trails the industry average.
  • The debt-to-equity ratio of 1.27 is relatively high when compared with the industry average, suggesting a need for better debt level management. Even though the debt-to-equity ratio is weak, PRAH's quick ratio is somewhat strong at 1.03, demonstrating the ability to handle short-term liquidity needs.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.